FDA Strikes Back: Rapid Approvals Combat Dangerous Screwworm Threat Near Texas

For decades, the United States has benefited from the historical eradication of one of the most devastating pests to plague warm-blooded animals: the New World Screwworm (NWS). While constant vigilance is maintained at our borders, on June 5, 2026, that threat became immediate.

Following an alert from the USDA regarding a specific NWS detection close to the Texas border, the Food and Drug Administration (FDA) moved with incredible speed. In a rare display of swift regulatory action, the agency issued multiple emergency and conditional approvals for veterinary drugs.

The goal? To rapidly treat animals and, crucially, to halt a widespread outbreak that could cripple the livestock industry and devastate domestic pet populations.

Here is what animal owners need to understand about the threat and the new tools available to fight it.

The Threat of the Screwworm

Unlike most common maggots that feed on dead tissue, New World Screwworms (larvae of the fly Cochliomyia hominivorax) are unique—and terrifying. The female flies lay their eggs in the smallest of open wounds on a live animal. Within hours, the larvae hatch and burrow deep into the living flesh, feeding on the animal.

An infestation can be rapidly fatal if not treated, causing immense pain and suffering to the animal. For American livestock producers and pet owners, it represents a significant economic and emotional crisis.

Because NWS reproduces quickly and flies migrate easily, a detection near the border requires an immediate "all-hands-on-deck" veterinary response to stop a massive infestation further inland.

Understanding the FDA’s Rapid Actions

Usually, the FDA drug approval process takes years of rigorous testing. However, federal law provides two critical pathways for emergency situations like this:

1. Conditional Approvals: This is for drugs intended for use in minor species, or minor uses in major species. It allows a drug to go to market with proof of safety and a "reasonable expectation" of effectiveness, with full data required later.
2. Emergency Use Authorizations (EUAs): Used only during declared public or animal health emergencies, EUAs authorize the temporary use of unapproved drugs (or new uses of approved drugs) with minimal immediate paperwork when the threat is severe.

The New Tools in the Arsenal

On June 5th, the FDA utilized these tools to issue three conditional approvals and nine EUAs. These actions specifically authorize targeted applications of established, highly effective parasite-killing ingredients to ensure they are immediately available for NWS treatment and containment.

Examples of specific drugs being deployed in the outbreak zone include:

• For Companion Dogs: Authorized use of products like Credelio Quattro-CA1, designed to rapidly treat existing screwworm infestations and prevent re-infestation.
• For Companion Cats: Deployment of targeted treatments like NexGard COMBO, giving feline owners a powerful tool in the fight against this parasite.
• For Livestock: Utilization of drugs like Exzolt Cattle-CA1, which can be applied easily to large groups of cattle to treat and prevent massive parasitic infestations in the agricultural supply chain.

By making these specialized treatments legally available overnight, the FDA has ensured that veterinarians on the ground have exactly what they need to protect individual animals and the agricultural landscape of the entire nation.

A Moment for Human Health: Colon Cancer Advancement

While the FDA was busy securing the nation’s borders from animal pests, significant progress was also announced in the realm of human cancer treatment.

On June 11, 2026, pharmaceutical leader Roche announced that the FDA had accepted its supplemental filing and granted Priority Review to Tecentriq (atezolizumab).

This immunotherapy drug is being reviewed for the treatment of stage III dMMR colon cancer. This specific designation of colon cancer is particularly difficult to treat with standard chemotherapy. While this is not a final approval, Priority Review places the drug on an accelerated track, promising a decision from the FDA months faster than a standard review would allow.

Final Thoughts

The beginning of June 2026 has been a significant week for public and animal health.

The presence of New World Screwworm near our borders is a sobering reminder of the constant vigilance required to protect our agricultural economy and our beloved companion animals. However, the FDA's decisive, rapid-fire response shows that our regulatory bodies are prepared to move mountains when the need is urgent.

If you are an animal owner in the Texas border region, please contact your veterinarian immediately for advice on inspecting your animals and utilizing the newly authorized protective measures. Together, we can ensure this threat is contained.